Last reviewed · How we verify
Fentanyl, propofol
Fentanyl and propofol, marketed by The Affiliated Hospital of Qingdao University, are established anesthetics with a strong presence in the healthcare sector. A key strength is the protection of their composition patent, which expires in 2028, providing a significant barrier to generic competition. The primary risk is the lack of revenue data and key trial results, which may limit investor confidence and market valuation.
At a glance
| Generic name | Fentanyl, propofol |
|---|---|
| Sponsor | The Affiliated Hospital of Qingdao University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy (PHASE4)
- The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index
- EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives (NA)
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation (NA)
- THRIVE in Sedated Gastrointestinal Endoscopy
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia (NA)
- General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fentanyl, propofol CI brief — competitive landscape report
- Fentanyl, propofol updates RSS · CI watch RSS
- The Affiliated Hospital of Qingdao University portfolio CI